๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Relapsing Remitting Multiple Sclerosis

A Prospective Randomized Non-inferiority Trial Comparing Anti-CD20 Maintenance Versus De-Escalation Strategy In Relapsing-Remitting Multiple Sclerosis NCT07189325Phase 31 site๐Ÿ“ Montpellier University Hospital, Montpellier ยท Tests: Platform therapies (Dimethyl Fumarate, Teriflunomide, Glatiramer Acetate, Beta-interferons), Anti-CD20 therapies (Ocrelโ€ฆ A Study to Evaluate the Preliminary Efficacy and Safety of Terfenadine in Patients With Relapsing-Remitting Multiple Sclerosis NCT07827716Phase 21 site๐Ÿ“ Wuhan Chuan Qin ยท Tests: Terfenadine, Standard First-line Disease-Modifying Therapy Definition of Autonomic Nervous System Involvement in Patients With Multiple Sclerosis NCT05748015NA2 sites๐Ÿ“ Telese Terme๐Ÿ“ Naples Istituti Clinici Scientifici Maugeri SpA ยท Tests: quantification of sensory and autonomic small nerve fibers by punch skin biopsy, Cardiovascular Reflexes testing, Adminโ€ฆ A Study of the Efficacy and Safety of BCD-281 in Patients With Relapsing-Remitting Multiple Sclerosis NCT07321093Phase 31 site๐Ÿ“ Nizhny Novgorod Biocad ยท Tests: BCD-281, Ocrelizumab Impact of the Cionic Neural Sleeve on Mobility in Multiple Sclerosis NCT05964829NA1 site๐Ÿ“ Cleveland Cionic, Inc. ยท Tests: Cionic Neural Sleeve NS-100, Walking Program A Study to Compare Efficacy, Pharmacokinetics, Pharmacodynamics and Safety of CT-P53 and Ocrevus in Patients With Relapsing-remitting Multiple Sclerosis NCT05906992Phase 31 site๐Ÿ“ Poznan Celltrion ยท Tests: CT-P53, US-Ocrevus, EU-Ocrevus Safety and Efficacy Study of Fingolimod in Taiwanese Adults (โ‰ฅ 20years) With Relapsing Remitting Multiple Sclerosis NCT04480853Phase 46 sites๐Ÿ“ Kaohsiung City๐Ÿ“ Taichung๐Ÿ“ Tainan Novartis Pharmaceuticals ยท Tests: Fingolimod Multiple Sclerosis Treatment With Autologous Hematopoietic Stem Cell Transplantation in the Netherlands NCT06567197n/a2 sites๐Ÿ“ Amsterdam๐Ÿ“ Nieuwegein Amsterdam UMC, location VUmc Wearable Focal Vibration Therapy on Upper Extremity Function of People With Multiple Sclerosis: A Pilot Study NCT07376772NA2 sites๐Ÿ“ Gainesville๐Ÿ“ Gainesville University of Florida ยท Tests: wearable focal vibration therapy REAL-MS: Observational Database Study of AHSCT and MS Therapies NCT07899502n/a3 sites๐Ÿ“ London๐Ÿ“ London๐Ÿ“ London Imperial College London ยท Tests: Autologous haematopoietic stem cell transplantation (AHSCT), High-efficacy disease-modifying therapy (HE-DMT) RRMS: Disease PROgression and Myeloid Profiling After Bone Marrow TRANSPLANTation and Second Line Therapies NCT06267781n/a1 site๐Ÿ“ Milan IRCCS San Raffaele Monthly Monitoring of Plasma NfL in Treated Relapsing-remitting Multiple Sclerosis to Detect Persistent Infraclinical Disease Activity NCT07292480NA2 sites๐Ÿ“ Nice๐Ÿ“ Nรฎmes Centre Hospitalier Universitaire de Nฤซmes ยท Tests: Monthly pNfL monitoring Clinnova-MS: A Prospective Cohort Study of Patients With Multiple Sclerosis (Switzerland) NCT06526364n/a1 site๐Ÿ“ Basel University Hospital, Basel, Switzerland ยท Tests: All participants will be asked to provide data and samples for collection and analysis. Sexual Dysfunction in Women With Multiple Sclerosis (MS) NCT07193823n/a1 site๐Ÿ“ Izmir Ege University Treatment of Cognitive Deficits in Multiple Sclerosis With High-Definition Transcranial Direct Current Stimulation NCT05958381NA1 site๐Ÿ“ Richardson The University of Texas at Dallas ยท Tests: Transcranial Direct Current Stimulation, Sham transcranial direct current stimulation Retinal Neuro-vascular Coupling in Patients With Multiple Sclerosis NCT03401879NA1 site๐Ÿ“ Vienna Medical University of Vienna ยท Tests: Dynamic Vessel Analyzer (DVA), Fourier Domain Doppler Optical Coherence Tomography (FDOCT), Optical coherence tomographโ€ฆ Non-interventional Study of Subcutaneous Ocrelizumab in Persons With Relapsing-Remitting Multiple Sclerosis NCT07827586n/a2 sites๐Ÿ“ Pardubice๐Ÿ“ Ljubljana Hoffmann-La Roche ยท Tests: Ocrelizumab Multiple Sclerosis and the Effects of Ketogenic Diet Therapy NCT06715436NA1 site๐Ÿ“ Pavia IRCCS National Neurological Institute "C. Mondino" Foundatiโ€ฆ ยท Tests: Mediterranean Diet, Ketogenic Diet, Control group Myrosinase Bioactivated Gglucoraphanin for the Treatment of Neurodegenerative Diseases (GRA-MYR-ND) NCT07360977NA1 site๐Ÿ“ Messina IRCCS Centro Neurolesi Bonino Pulejo ยท Tests: bioactivated GRA for adult patients, bioactivated GRA for pediatric patients MS-ResearchBiomarkerS NCT05204459n/a1 site๐Ÿ“ Los Angeles Cedars-Sinai Medical Center TOTEM RRMS : TestOsterone TreatmEnt on Neuroprotection and Myelin Repair in Relapsing Remitting Multiple Sclerosis NCT03910738Phase 25 sites๐Ÿ“ Besanรงon๐Ÿ“ Nancy๐Ÿ“ Paris University Hospital, Strasbourg, France ยท Tests: Nebidoยฎ Testosterone Undecanoate 1000 Mg/4 mL Solution for Injection, Placebo 4 mL Solution for Injection, MRI, Assessmโ€ฆ The SetPoint System as a Pro-Remyelination Therapy for Relapsing-Remitting Multiple Sclerosis: A Pilot Study NCT06796504NA9 sites๐Ÿ“ Irvine๐Ÿ“ Atlanta๐Ÿ“ Baltimore SetPoint Medical Corporation ยท Tests: Implant Procedure, Disease-Modifying Therapies (DMTs), Active stimulation, Non-active stimulation Non-inferiority Study of Rituximab Compared to Ocrelizumab in Relapsing MS NCT05834855Phase 31 site๐Ÿ“ Amsterdam Amsterdam UMC, location VUmc ยท Tests: Rituximab A Study of Rocbrutinib in PRL-Positive Relapsing-Remitting Multiple Sclerosis NCT07776743Phase 21 site๐Ÿ“ Beijing Guangzhou Lupeng Pharmaceutical Company LTD. ยท Tests: Rocbrutinib, Dimethyl Fumarate Relationship Between Single- and Dual-Task Obstacle Crossing Performance and Fatigue and Disability in Multiple Sclerosis NCT07736482n/a1 site๐Ÿ“ Afyonkarahisar Afyonkarahisar Health Sciences University Effects of Acute Intermittent Hypoxia on Neuroplasticity in MS NCT06390930NA1 site๐Ÿ“ Chicago Shirley Ryan AbilityLab ยท Tests: Acute Intermittent Hypoxia, Sham Acute Intermittent Hypoxia Intermittent Hypoxia in Persons With Multiple Sclerosis NCT06276634NA1 site๐Ÿ“ Chicago Shirley Ryan AbilityLab ยท Tests: Acute Intermittent Hypoxia, Sham-Acute Intermittent Hypoxia Brain Imaging and Immune Changes During Remibrutinib Treatment in Multiple Sclerosis. NCT07758270n/a1 site๐Ÿ“ St Louis Washington University School of Medicine ยท Tests: Remibrutinib, Ocrelizumab (US) Effects of Ublituximab on Motor Functions in Multiple Sclerosis NCT06629428EARLY Phase 12 sites๐Ÿ“ Atlanta๐Ÿ“ Atlanta Georgia State University ยท Tests: Ublituximab Indole-3-PROpionic Acid Clinical Trials - Multiple Sclerosis NCT07318129NA1 site๐Ÿ“ Glostrup Municipality Glostrup University Hospital, Copenhagen ยท Tests: Placebo, Indole-3-propionic acid (IPA)
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy